DNA & Genetics Making In Vivo Progress in CAR Therapeutic DevelopmentBy adminFebruary 3, 20260 Researchers use in vivo chimeric antigen receptor (CAR) approaches to reprogram immune cells inside living systems, offering more efficient alternatives…
Microbiome With Gordian Bio’s In Vivo Platform, Pfizer Revamps Obesity Target DiscoveryBy adminJanuary 8, 20260 Credit: unoL / iStock / Getty Images Plus Drug development is in a preclinical testing predicament. With advances in artificial…
Microbiome In Vivo Gene Editing for Rare Diseases Begins with Umbrella Clinical TrialBy adminNovember 1, 20250 Credit: Blablo101 / iStock / Getty Images Plus It’s been less than six months since the news of Baby KJ…
Microbiome Bristol Myers Squibb Moves Into In Vivo CAR T with $1.5 Billion Orbital BuyBy adminOctober 11, 20250 Credit: Pixelbizz/Getty Images Big pharma Bristol Myers Squibb (BMS) has agreed to acquire RNA biotech Orbital Therapeutics for $1.5 Billion.…
